What does AMPLY Discovery do?
AMPLY Discovery is an AI drug discovery startup based in Belfast, Northern Ireland, that specializes in developing gene-silencing therapies for diseases such as breast cancer, acute myeloid leukaemia, and lung infections.
How much did they raise?
The company raised $1.75M in a Seed round led by Twin Path Ventures, with participation from Venture Science, Co-fund NI, the British Business Bank, and QUBIS Limited.
What are their plans for the money?
AMPLY Discovery plans to use the funds to further advance its portfolio of medicines, accelerating the development and potential impact of its gene-silencing technology in treating critical diseases.
What have they achieved so far?
Spun out of Queen’s University Belfast by Dr. Ben Thomas, Dermot Tierney, and Prof. Chris Creevey, the startup has already made strides in its research, laying a strong foundation for future innovation in AI-enabled drug discovery.
